Enovis Corp. (ENOV)

26.32 +1.12 (+4.44%) USD  |  NYSE  |  Apr 17, 16:00
26.04 -0.28 (-1.06%) Pre-Market: 08:20
More

Enovis SG&A Expense (Quarterly) : 270.44M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ENOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Integra LifeSciences Holdings Corp. 169.27M
Globus Medical, Inc. 318.48M
Abbott Laboratories 3.74B
Accuray, Inc. 18.91M
Plus Therapeutics, Inc. 4.168M